© 2020 MJH Life Sciences and Endocrinology Network. All rights reserved.
January 22, 2020
The FDA announced yesterday that it has approved the first treatment for thyroid eye disease: teprotumumab-trbw (Tepezza, Horizon Therapeutics).
May 22, 2019
Restoring normal thyroid function may reverse cold-induced thermogenesis, say researchers writing in the journal Thyroid.
Adults with subclinical hypothyroidism do not need thyroid hormone therapy in most cases, states a BMJ Rapid Recommendation issued this month.